drugset / Trial / NCT00807989

The Efficacy and Safety of Low Dose Combination of LTG and VPA Compared to CBZ Monotherapy

NCT00807989

Phase 4 Completed 207 enrolled Yonsei University
RandomizedParallel-groupOpen-labelTreatment

Summary

To evaluate the efficacy of usual monotherapy and low dose combination of Lamotrigine and Valproate. Low dose combination may be more effective and tolerable because they are low dose and VPA reduce Lamotrigine metabolism.

Timeline

Start
2008-03
Primary completion
2012-05
Completion
2012-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Carbamazepine Small molecule
Subject Lamotrigine Small molecule
Subject Valproate Small molecule

Indications